Article Details

Intec Pharma (NASDAQ:NTEC) Rating Increased to Hold at Zacks Investment Research

Retrieved on: 2021-03-09 08:26:15

Tags for this article:

Click the tags to see associated articles and topics

Intec Pharma (NASDAQ:NTEC) Rating Increased to Hold at Zacks Investment Research. View article details on hiswai:

Excerpt

Renaissance Technologies LLC grew its holdings in shares of Intec ... drugs based on its proprietary Accordion Pill platform technology in Israel.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up